TOP ROW FROM LEFT TO RIGHT: Daniel Probert Research Associate, Process Development, Henry Hodge Business Development Associate, Sarah Hale Senior Scientist, Analytical Development, Sarah Sebastian Director, Research and Development, Chris Ellis Chief Operating Officer, Alison Turner Director, Process Development, Dr Tom Evans CEO, Vesa Qarkaxhija Clinical Trials Administrator, Lawrence Petherbridge Research Associate, Molecular Virology, Vicky Wheeler Programme Manager.
BOTTOM ROW FROM LEFT TO RIGHT: Graham Griffiths Chief Business Officer, Stella Ackrell Senior Project Manager, Manufacturing, Frederick Momoh Research Associate, Early Development Lab/Process Development, Jamie Comley Laboratory Technician, Denise McCarron Clinical Trials Administrator, Angela Robinson Research Associate, Analytical Development, Keith Howard Chief Development Officer, Elizabeth Eagling-Vose Head of Clinical Operations, Kinga Piotrowska Research Associate, Early Development Lab/Process Development, Pippa Rathbone Executive Administrator, Louise Bussey Clinical Study Manager.
NOT PRESENT: Bernie Macdonald Head of IP, Dalila Karbiche Clinical Study Manager – Consultant, Barsha Thapa Research Associate, Early Development Lab/Process Development, Sophie Jameson Part-time Research Associate, Process Development, Gwen Tucker Clinical Study Manager, Daniel Jones Senior Scientist, MD Forazi Senior Scientist, Linda Kelly Programme Manager.
Dr. Thomas G. Evans
Chief Medical Officer
Mariem Charafeddine received her M.D. from the University of Casablanca, Faculty of Medicine and Pharmacy in Morocco. She is also an alumni of ESCP Europe Business School.
As part of her career in Europe and the USA, she has held several positions in medical affairs, clinical development and pharmacovigilance in multinational pharmaceutical companies. Her areas of expertise include infectious diseases and hepatology.
Mariem joined Vaccitech as Chief Medical Officer on July 15, 2019.
Dr Keith Howard
Professor of Vaccinology
Professor Adrian Hill
Board of Directors
Robin Wright has extensive senior level experience as a CFO of public companies in both the pharmaceutical and biotechnology industries. He is a qualified accountant and currently Chief Financial Officer of the biopharmaceutical company Pharming Group NV in the Netherlands.
Robin joined Pharming from Sweden-based Karolinska Development AB (publ.) (KDEV: SS), where he was CFO and Head of Business Development. Mr. Wright was CFO and Head of Business Development at Orexo AB (publ.) (ORX: SS) in Sweden prior to this. Before going to Sweden, he worked in private equity and corporate finance advisory roles, including long periods at Citibank Salomon Smith Barney and Barclays de Zoete Wedd. He has completed over 170 global license and M&A transactions as well as several hundred financing transactions in debt and equity within the pharma/ biotech sector. Mr. Wright holds a BA degree in Chemistry from Oxford University and is a Fellow of the Institute of Chartered Accountants in England and Wales in the UK.